K+S stock holds at EUR 12.42 as earnings remain the key test

Published on 09/22/2026 at 10:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

K+S stock traded at EUR 12.42 on September 22, 2026, while the latest half-year figures showed revenue of EUR 1.96 billion. EBITDA reached EUR 229 million.

Draufsicht auf Aktienzertifikat DE000KSAG888 mit Kali-Gesteinsproben, Schutzhelm, Lupe und Chart — K+S AG Aktien-Flatlay DE000KSAG888 mit Aktienzertifikat rosa Kalimineralien Bergbauhelm Lupe und gedrucktem Kursdiagramm, Illustration mit AI erstellt.

K+S stock traded at EUR 12.42 on the primary Xetra market on September 22, 2026, giving investors a dated market reference as the fertilizer producer approaches its next results checkpoint. The latest reported figures remain the central measure of operating performance: revenue reached EUR 1.96 billion in the first half of fiscal year 2026, while EBITDA stood at EUR 229 million.

Half-year figures set the baseline

K+S reported revenue of EUR 1.96 billion for the first half of fiscal year 2026, compared with EUR 1.91 billion in the same period of fiscal year 2025, an increase of EUR 50 million. EBITDA reached EUR 229 million in the first half of fiscal year 2026, versus EUR 231 million a year earlier, a decline of EUR 2 million.

The comparison shows why the revenue figure alone does not define the investment case. Sales were higher by 2.6 percent year over year, while EBITDA was 0.9 percent lower. For investors, the next update therefore hinges on whether pricing and cost control can convert sales into operating earnings.

Price keeps the market signal clear

The Xetra reference price was EUR 12.42 as of September 22, 2026. The quoted level gives the stock a concrete reference point for the next company update, while the half-year comparison places the market data against an operating result that was broadly stable in absolute terms.

K+S operates in the chemicals sector, with potash and salt as its principal business areas. That mix leaves earnings sensitive to fertilizer prices, demand conditions and production costs, so revenue growth of 2.6 percent and the 0.9 percent EBITDA decline provide a more useful signal than the sales figure alone.

Stock remains tied to earnings delivery

K+S stock stood at EUR 12.42 on Xetra on September 22, 2026. The dated price and the first-half figures together frame the next valuation debate around operating conversion: revenue improved by EUR 50 million, but EBITDA slipped by EUR 2 million.